Literature DB >> 20618892

Gluconic acid production by Aspergillus terreus.

C Dowdells1, R L Jones, M Mattey, M Bencina, M Legisa, D M Mousdale.   

Abstract

AIM: Aspergillus terreus produces itaconic acid at low pH but lovastatin and other secondary metabolites at higher pH in the fermentation. The utilization of glucose as a carbon substrate was investigated for secondary metabolite production by A. terreus. METHODS AND
RESULTS: With a starting pH of 6.5, glucose was rapidly metabolized to gluconic acid by the wild-type strain and by transformants harbouring Aspergillus niger genes encoding 6-phosphofructo-1-kinases with superior kinetic and regulatory properties for bioproduction of metabolites from glucose. On exhaustion of the glucose in batch fermentations, the accumulated gluconic acid was utilized as a carbon source.
CONCLUSIONS: A novel pathway of glucose catabolism was demonstrated in A. terreus, a species whose wild type is, without any strain development, capable of producing gluconic acid at high molar conversion efficiency (up to 0.7 mol mol(-1) glucose consumed). SIGNIFICANCE AND IMPACT OF THE STUDY: Aspergillus terreus is a potential novel producer organism for gluconic acid, a compound with many uses as a bulk chemical. With a new knowledge of glucose catabolism by A. terreus, fermentation strategies for secondary metabolite production can be devised with glucose feeding using feedback regulation by pH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618892     DOI: 10.1111/j.1472-765X.2010.02890.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  7 in total

1.  Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus.

Authors:  Ajay P Nayak; Brett J Green; Erika Janotka; Justin M Hettick; Sherri Friend; Steve J Vesper; Detlef Schmechel; Donald H Beezhold
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

2.  Plasmalyte: No Longer a Culprit in Causing False-Positive Galactomannan Test Results.

Authors:  Isabel Spriet; Katrien Lagrou; Johan Maertens; Ludo Willems; Alexander Wilmer; Joost Wauters
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

3.  Galactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; John R Witt; Michelle M Durkin; John D Bacher; L Joseph Wheat; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

4.  Characterization of L-arabinose/D-galactose 1-dehydrogenase from Thermotoga maritima and its application in galactonate production.

Authors:  Mengke Xue; Sizhong Feng; Fang Xie; Hongyang Zhao; Yemin Xue
Journal:  World J Microbiol Biotechnol       Date:  2022-09-16       Impact factor: 4.253

Review 5.  Production of lovastatin and itaconic acid by Aspergillus terreus: a comparative perspective.

Authors:  Tomasz Boruta; Marcin Bizukojc
Journal:  World J Microbiol Biotechnol       Date:  2017-01-19       Impact factor: 3.312

6.  Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Chadi A Hage; Eva M Carmona; Oleg Epelbaum; Scott E Evans; Luke M Gabe; Qusay Haydour; Kenneth S Knox; Jay K Kolls; M Hassan Murad; Nancy L Wengenack; Andrew H Limper
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

7.  Fungal Growth in Batch Culture - What We Could Benefit If We Start Looking Closer.

Authors:  Pamela Vrabl; Christoph W Schinagl; Desirée J Artmann; Benedikt Heiss; Wolfgang Burgstaller
Journal:  Front Microbiol       Date:  2019-10-16       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.